MLTX logo

MoonLake Immunotherapeutics (MLTX) Cash From Investing

Annual CFI:

-$205.60M-$180.41M(-716.36%)
December 31, 2024

Summary

  • As of today, MLTX annual cash from investing is -$205.60 million, with the most recent change of -$180.41 million (-716.36%) on December 31, 2024.
  • During the last 3 years, MLTX annual cash from investing has fallen by -$205.54 million (-405413.41%).
  • MLTX annual cash from investing is now -405413.41% below its all-time high of -$50.70 thousand, reached on December 31, 2021.

Performance

MLTX Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLTXcash flow metrics

Quarterly CFI:

$88.25M+$32.01M(+56.91%)
June 30, 2025

Summary

  • As of today, MLTX quarterly cash from investing is $88.25 million, with the most recent change of +$32.01 million (+56.91%) on June 30, 2025.
  • Over the past year, MLTX quarterly cash from investing has increased by +$176.00 million (+200.58%).
  • MLTX quarterly cash from investing is now -24.48% below its all-time high of $116.87 million, reached on December 31, 2023.

Performance

MLTX Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLTXcash flow metrics

TTM CFI:

$55.45M+$176.00M(+146.00%)
June 30, 2025

Summary

  • As of today, MLTX TTM cash from investing is $55.45 million, with the most recent change of +$176.00 million (+146.00%) on June 30, 2025.
  • Over the past year, MLTX TTM cash from investing has increased by +$229.51 million (+131.86%).
  • MLTX TTM cash from investing is now -5.38% below its all-time high of $58.60 million, reached on September 30, 2024.

Performance

MLTX TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLTXcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

MLTX Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-716.4%+200.6%+131.9%
3Y3 Years-10000.0%+100.0%+10000.0%
5Y5 Years-78.8%--

MLTX Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year>-9999.0%at low-24.5%+150.6%-5.4%+127.0%
5Y5-Year>-9999.0%at low-24.5%+150.6%-5.4%+127.0%
All-TimeAll-Time>-9999.0%at low-24.5%+150.6%-5.4%+127.0%

MLTX Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
$88.25M(+56.9%)
$55.45M(+146.0%)
Mar 2025
-
$56.25M(+138.2%)
-$120.55M(+41.4%)
Dec 2024
-$205.60M(-716.4%)
-$147.33M(-352.8%)
-$205.60M(-450.8%)
Sep 2024
-
$58.28M(+166.4%)
$58.60M(+133.7%)
Jun 2024
-
-$87.74M(-204.6%)
-$174.06M(-136.4%)
Mar 2024
-
-$28.80M(-124.6%)
-$73.64M(-192.4%)
Dec 2023
-$25.18M
$116.87M(+167.0%)
-$25.18M(+80.9%)
Sep 2023
-
-$174.38M(-1475.6%)
-$132.15M(>-9900.0%)
Jun 2023
-
$12.68M(-35.5%)
$0.00(+100.0%)
DateAnnualQuarterlyTTM
Mar 2023
-
$19.65M(+98.4%)
-$12.68M(+60.8%)
Dec 2022
-$32.34M(>-9900.0%)
$9.90M(+123.4%)
-$32.34M(+23.5%)
Sep 2022
-
-$42.23M(>-9900.0%)
-$42.26M(>-9900.0%)
Jun 2022
-
$0.00(+100.0%)
-$46.00K(+31.0%)
Mar 2022
-
-$16.00K(+13.0%)
-$66.70K(-31.6%)
Dec 2021
-$50.70K(+100.0%)
-$18.40K(-58.6%)
-$50.70K(+100.0%)
Sep 2021
-
-$11.60K(+44.0%)
-$115.03M(-0.0%)
Jun 2021
-
-$20.70K(>-9900.0%)
-$115.02M(-0.0%)
Mar 2021
-
$0.00(+100.0%)
-$115.00M(0.0%)
Dec 2020
-$115.00M
-$115.00M
-$115.00M

FAQ

  • What is MoonLake Immunotherapeutics annual cash from investing?
  • What is the all-time high annual cash from investing for MoonLake Immunotherapeutics?
  • What is MoonLake Immunotherapeutics annual cash from investing year-on-year change?
  • What is MoonLake Immunotherapeutics quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for MoonLake Immunotherapeutics?
  • What is MoonLake Immunotherapeutics quarterly cash from investing year-on-year change?
  • What is MoonLake Immunotherapeutics TTM cash from investing?
  • What is the all-time high TTM cash from investing for MoonLake Immunotherapeutics?
  • What is MoonLake Immunotherapeutics TTM cash from investing year-on-year change?

What is MoonLake Immunotherapeutics annual cash from investing?

The current annual cash from investing of MLTX is -$205.60M

What is the all-time high annual cash from investing for MoonLake Immunotherapeutics?

MoonLake Immunotherapeutics all-time high annual cash from investing is -$50.70K

What is MoonLake Immunotherapeutics annual cash from investing year-on-year change?

Over the past year, MLTX annual cash from investing has changed by -$180.41M (-716.36%)

What is MoonLake Immunotherapeutics quarterly cash from investing?

The current quarterly cash from investing of MLTX is $88.25M

What is the all-time high quarterly cash from investing for MoonLake Immunotherapeutics?

MoonLake Immunotherapeutics all-time high quarterly cash from investing is $116.87M

What is MoonLake Immunotherapeutics quarterly cash from investing year-on-year change?

Over the past year, MLTX quarterly cash from investing has changed by +$176.00M (+200.58%)

What is MoonLake Immunotherapeutics TTM cash from investing?

The current TTM cash from investing of MLTX is $55.45M

What is the all-time high TTM cash from investing for MoonLake Immunotherapeutics?

MoonLake Immunotherapeutics all-time high TTM cash from investing is $58.60M

What is MoonLake Immunotherapeutics TTM cash from investing year-on-year change?

Over the past year, MLTX TTM cash from investing has changed by +$229.51M (+131.86%)
On this page